Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honey Globin Syrup is a hematinic supplement developed and marketed by Taqwa Pharmaceuticals. It is primarily indicated for the prevention and treatment of iron-deficiency anemia and other nutritional deficiencies. The formulation typically combines essential nutrients required for erythropoiesis, including iron (often in the form of ferric ammonium citrate), cyanocobalamin (Vitamin B12), and folic acid. These components serve as critical substrates and cofactors for the synthesis of hemoglobin and the production of healthy red blood cells. The product is formulated as an oral syrup with a honey-flavored base to enhance palatability, making it suitable for patients with increased nutritional demands, such as during pregnancy, lactation, or recovery from illness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Honey Globin Syrup.